Critical Care
Deaths Lead to Withdrawal of Cholesterol Drug
The FDA has announced that Bayer Pharmaceutical Division is voluntarily withdrawing the lipid-lowering drug cerivastatin (Baycol) from the market because of reports of sometimes fatal rhabdomyolysis, a severe muscle adverse reaction from the drug. More...16 Aug 2001
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
LED Surgical Lamp
ACEMST35/57
Ultrasound Needle Guidance System
SonoSite L25
In Other News
Increased Drug-Related Visits to Emergency Departments
Predictions on Future Respiratory Care
Global Alliance in Hemostasis Extended
Cardiologists to Convene in Stockholm
Low Survival after Emergency Drug-Free Intubation
Metabolic Autopsy May Explain Some SIDS Cases
Initiative to Teach Palliative Care to Medical Students
Blood Pressure Monitor Suitable for Children
No Intensive Care for Dutch Babies Under 25 Weeks
Cardioverter Defibrillator Minimizes Inappropriate Shocks
Gene Transfer Vaccine for Malignant Melanoma
Enhanced Information System for Analyzer Data
New Therapy for Heart Valve Leaks
Two Drugs Slash Risk of Stroke Recurrence
Faster Ambulance Response Could Cut Deaths
Study Supports Use of Bilirubin Analyzer
Drug Combo Reduces Second Heart Attack Risk
Rubber-Stoppered Vials Pose Latex Allergy Risk
New Guidelines Issued on Equipping Ambulances
Fast New Analyzer for Critical Care
Insights from PAT on Sleep Disorders and Heart Problems
Global Summit on Combating "Superbugs”
Small Heart-Lung Machine May Lead to Faster Recovery
HospiMedica Critical Care channel provides timely reporting on emergency medicine, intensive care, anesthesia, neonatal care, patient monitoring, respiratory care, infection control, and more hospital related subjects.